Shares of food-delivery company Swiggy surged 1.7% to their day’s high of Rs 587.30 on the BSE as the global brokerage firm JP Morgan has initiated coverage on the stock with an ‘overweight’ rating and a target price of Rs 730. This indicates an upside potential of 26.5% for the stock from the current levels….
READ MOREShares of Piramal Pharma soared 8.3% to their day’s high of Rs 272 on the BSE after the domestic brokerage firm JM Financial initiated coverage on the healthcare sector, citing the stock as its preferred pick with a target price of Rs 340. The target price stated by the domestic brokerage firm signals an upside…
READ MOREShares of newly-listed Swiggy climbed as much as 8.1% on Wednesday to Rs 499 on BSE, with the stock surging nearly 16% in the past two sessions after UBS became the latest brokerage to initiate coverage on the food delivery major with a “Buy” rating, highlighting Swiggy’s promising growth in India’s food delivery and quick…
READ MOREIn today’s dynamic market, we frequently witness indices scaling new heights, with the latest milestone being the Nifty crossing 25,000 mark. Amidst these high valuations, one sector stands out with strong growth potential—the Indian pharmaceutical industry. Often seen as a contrarian or defensive investment, this sector provides a powerful hedge against market volatility while energizing…
READ MORE